NYSE: ABT · Medical Devices
Over the past week, Abbott Laboratories (ABT) racked up about 122 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 37% bullish but is at odds: X runs 53% bullish while News sits at just 12%. Wall Street is more constructive, with 20 of 27 analysts rating ABT a buy.
There is steady buzz around ABT this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 74% buy share sits next to a crowd that ranges from News at 12% to X at 53%. No other tracker puts the two side by side.
27 analysts have weighed in: a Strong Buy consensus: 20 buy calls against 0 sell, with an average 12-month price target of $120.20.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 37 points above the crowd average of 37%, the professionals are more constructive than retail. The split is inside the crowd: X reads 53% bullish while News sits at 12%, a 41-point spread that single-source trackers miss.
Over the 30-day window, Abbott Laboratories (ABT) buzz held subdued around 39.1 while the price drifted up 6.4% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 7.7M shares. Updated Aug 29, 2026. Over the last 7 trading days, ABT lost 1.5%. Buzz activity in the recent week averaged 42.0 and was relatively stable, swinging between 30.7 and 49.2. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 16 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for ABT and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ABT sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 29, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (20 / 7 / 0) |
| Crowd bullish (7d) | 37% |
| Avg price target | $120.20 |
| Most bullish source | X, 53% |
| Most bearish source | News, 12% |
| Sentiment spread | 41 pts |
| Mentions (7d) | 122 |
| Market cap | $193.09B |
| P/E · Forward P/E | 37.0 · 20.7 |
| EPS · Beta | $3.02 · 0.6 |
| Revenue (TTM) | $46.59B · 12% margin |
| Industry | Medical Devices |
Based on aggregated sentiment from Reddit, X and News sources, Abbott Laboratories (ABT) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 37% bullish across 3 active sources. Those sources contribute 122 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Abbott Laboratories (ABT) is fairly quiet with 20 mentions over the last 7 days; the 30-day context spans 18 tracked subreddits. The 7-day tone is 45% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bearish on Abbott Laboratories (ABT), averaging 37% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 53% bullish and News at 12%, a 41-point spread. On the professional side, 20 of 27 analysts rate ABT a buy.
Of the 27 analysts covering Abbott Laboratories (ABT), 20 rate it a buy, 7 a hold and 0 a sell, for a strong buy consensus. The average price target is $120.20. That puts the street ahead of the crowd, which averages 37% bullish.
Abbott Laboratories (ABT)'s cross-source average is bearish at 37% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. Reddit reads 45% bullish, X reads 53% bullish and news coverage is the most negative at 12% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Abbott Laboratories (ABT) at 37% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is news at 12% bullish. 3-day activity momentum is falling across Reddit and X and News. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 57 mentions (47% of total volume). X contributes 45 mentions and Reddit contributes 20 mentions. The cross-source average is bearish at 37% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ABT's sell signal at 93/100 conviction reflects a bearish cross-source average at 37% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The ABT sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key